The State of America's Direct Support Workforce Crisis 2024

New report sheds light on persistent problems facing community providers due to ongoing recruitment and retention challenges
Browse the Data
Capitol Correspondence - 05.24.22

Expanded Eligibility for COVID-19 Boosters

Share this page

The Food & Drug Administration has expanded eligibility for the Pfizer COVID-19 vaccine booster to children ages 5 to 11 who completed their primary series at least five months ago. The Centers for Disease Control & Prevention’s (CDC) vaccine advisory panel met Thursday and voted in favor of approval, with the CDC itself giving its approval shortly thereafter. The authorization makes all children 5 and older who received their second shot at least five months ago eligible to receive a third shot of the Pfizer-BioNTech vaccine. Until now, only children ages 12 and older and adults were eligible for a booster.

More News

Capitol Correspondence - 11.19.24
ACL to Host Webinar on Preparing for Extreme Weather
Capitol Correspondence - 11.19.24
CMS to Host Leadership National Call
Capitol Correspondence - 11.12.24
NIH Engages in Strategic Planning